𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Overview of Drugs in Arterial Thrombosis [and Discussion]

✍ Scribed by Meade, T. W.; McMichael, J.


Book ID
120152193
Publisher
The Royal Society
Year
1981
Tongue
English
Weight
409 KB
Volume
294
Category
Article
ISSN
0080-4622

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Therapeutic approaches in arterial throm
✍ D. R. PHILLIPS; P. B. CONLEY; U. SINHA; P. ANDRE πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 344 KB
Antithrombotic Drug Therapy in Cardiovas
✍ Askari, Arman T.; Lincoff, A. Michael πŸ“‚ Article πŸ“… 2009 πŸ› Humana Press 🌐 English βš– 962 KB

Substantial morbidity and mortality remains associated with thrombotic events has stimulated the rapid expansion of the available armamentarium to combat pathologic thrombosis. Pathologic thrombosis plays an essential role in the pathogenesis of acute coronary syndromes (ACS), ischemic complications

Overview of the 2006 Food and Drug Admin
✍ Tina L. Pinto Slottow; Ron Waksman πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 155 KB πŸ‘ 1 views

## Abstract Drug‐eluting stents (DES) seemed likely to mitigate the problem of restenosis and have become the predominant stent deployed during percutaneous coronary intervention (PCI). Sustained concerns about the rate of stent thrombosis (ST), particularly very late ST (>1 year following PCI) led